SOPH
SOPHiA GENETICS S.A. NASDAQ Listed Jul 23, 2021$5.40
Pre-mkt
$4.75
+2.69%
Mkt Cap $387.0M
52w Low $2.59
90.4% of range
52w High $5.70
50d MA $4.85
200d MA $4.42
P/E (TTM)
-4.5x
EV/EBITDA
-5.0x
P/B
7.6x
Debt/Equity
1.3x
ROE
—
P/FCF
-8.2x
RSI (14)
—
ATR (14)
—
Beta
1.04
50d MA
$4.85
200d MA
$4.42
Avg Volume
128.7K
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Rue du Centre 172 · Rolle, V8 1025 · CH
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | BMO | -0.24 | -0.28 | -17.9% | 4.10 | +0.5% | +2.9% | +0.0% | +2.6% | +0.5% | +2.5% | — |
| Nov 4, 2025 | BMO | -0.20 | -0.30 | -50.0% | 4.68 | -3.0% | -3.4% | +0.0% | +4.9% | -7.8% | -0.5% | — |
| Aug 5, 2025 | BMO | -0.21 | 0.33 | +257.1% | 3.42 | -7.9% | -7.9% | +0.0% | +1.6% | -0.6% | -5.3% | — |
| May 6, 2025 | BMO | -0.21 | -0.26 | -23.8% | 3.00 | +3.0% | +0.0% | +0.0% | -0.3% | -2.0% | +8.9% | — |
| Mar 4, 2025 | BMO | -0.23 | -0.23 | +0.0% | 3.10 | +5.5% | +0.3% | +0.0% | +0.0% | +4.2% | -0.9% | — |
| Nov 5, 2024 | BMO | -0.24 | -0.28 | -16.7% | 3.75 | -9.3% | -9.3% | +0.0% | +0.0% | +3.5% | +7.7% | — |
| Aug 6, 2024 | BMO | -0.28 | -0.23 | +17.9% | 4.06 | +0.0% | -10.1% | +0.0% | -7.9% | -3.6% | -1.5% | — |
| May 7, 2024 | BMO | -0.25 | -0.21 | +16.0% | 4.97 | +1.6% | -7.4% | +0.0% | +4.8% | -2.7% | -2.3% | — |
| Mar 5, 2024 | BMO | -0.25 | -0.37 | -48.0% | 5.60 | -8.0% | -10.5% | +0.0% | -0.4% | -5.2% | +2.5% | — |
| Nov 7, 2023 | BMO | -0.32 | -0.21 | +34.4% | 3.91 | -4.1% | +0.0% | +0.0% | -0.8% | -12.4% | -5.3% | — |
| Aug 8, 2023 | BMO | -0.29 | -0.33 | -13.8% | 3.55 | -2.5% | +1.7% | +0.0% | -6.4% | -9.2% | -2.3% | — |
| May 9, 2023 | BMO | -0.28 | -0.31 | -10.7% | 4.85 | +0.2% | -4.5% | +0.0% | +0.0% | -2.6% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | BTIG | Maintains | Buy → Buy | — | $4.96 | $4.96 | +0.0% | +2.2% | +1.0% | +3.1% | -1.7% | -1.3% |
| Jan 26 | Guggenheim | Maintains | Buy → Buy | — | $5.36 | $5.36 | +0.0% | -0.7% | -1.3% | +0.0% | -1.5% | +1.5% |
| Nov 10 | BTIG | Maintains | Buy → Buy | — | $4.37 | $4.37 | +0.0% | -0.5% | +6.2% | -6.5% | +1.4% | -1.6% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $4.06 | $4.06 | +0.0% | -10.1% | -7.9% | -3.6% | -1.5% | +6.3% |
| Mar 6 | BTIG | Maintains | Buy → Buy | — | $5.60 | $5.15 | -8.0% | -10.5% | -0.4% | -5.2% | +2.5% | -3.9% |
| Mar 6 | RBC Capital | Maintains | Outperform → Outperform | — | $5.60 | $5.15 | -8.0% | -10.5% | -0.4% | -5.2% | +2.5% | -3.9% |
| Jan 12 | RBC Capital | Maintains | Outperform → Outperform | — | $5.50 | $5.46 | -0.7% | -4.9% | -12.6% | +0.4% | -1.7% | -0.2% |
| May 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $4.85 | $4.86 | +0.2% | -4.5% | +0.0% | -2.6% | -1.1% | -5.2% |
| May 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.85 | $4.86 | +0.2% | -4.5% | +0.0% | -2.6% | -1.1% | -5.2% |
| Mar 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $2.53 | $2.60 | +2.8% | +21.7% | +7.8% | +4.2% | +4.9% | +37.5% |
| Jan 3 | BTIG | Maintains | Buy → Buy | — | $2.06 | $2.19 | +6.3% | +9.2% | -2.2% | -1.8% | -8.3% | +13.1% |
| Nov 23 | Credit Suisse | Maintains | Neutral → Neutral | — | $2.00 | $1.96 | -2.0% | +0.0% | +4.0% | -2.4% | +7.4% | +6.0% |
| Nov 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $1.84 | $1.76 | -4.3% | -7.1% | +17.0% | +14.0% | -10.5% | +0.5% |
| Aug 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.79 | $5.00 | +4.4% | +2.3% | +3.1% | -5.0% | -6.2% | -1.1% |
| May 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.91 | $5.00 | +1.8% | +6.5% | -5.2% | -3.0% | +0.2% | +3.3% |
| Mar 16 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.21 | $8.20 | -0.1% | +2.7% | +2.6% | -1.3% | -0.9% | -1.5% |
| Feb 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $11.59 | $11.73 | +1.2% | +5.1% | +0.9% | -1.1% | -4.1% | +2.9% |
| Aug 17 | Credit Suisse | Maintains | Outperform → Outperform | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | JP Morgan | Maintains | Overweight → Overweight | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | Cowen & Co. | Maintains | Outperform → Outperform | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 8,500 | $5.09 | $43K | 3,633,981 | — | — |
| Apr 27, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $4.82 | $24K | 261,388 | +5.60% | -4.16% |
No recent filings available.
Data updated apr 27, 2026 2:27am
· Source: massive.com